Culture

A single gene 'invented' haemoglobin several times

image: The Platynereis dumerilii vascular system in three segments

Image: 
© Song et al. / BMC Evolutionary Biology

Thanks to the marine worm Platynereis dumerilii, an animal whose genes have evolved very slowly, scientists from CNRS, Université de Paris and Sorbonne Université, in association with others at the University of Saint Petersburg and the University of Rio de Janeiro, have shown that while haemoglobin appeared independently in several species, it actually descends from a single gene transmitted to all by their last common ancestor. These findings were published on 29 December 2020 in BMC Evolutionary Biology.

Having red blood is not peculiar to humans or mammals. This colour comes from haemoglobin, a complex protein specialized in transporting the oxygen found in the circulatory system of vertebrates, but also in annelids (a worm family whose most famous members are earthworms), molluscs (especially pond snails) and crustaceans (such as daphnia or 'water fleas'). It was thought that for haemoglobin to have appeared in such diverse species, it must have been 'invented' several times during evolution. But recent research has shown that all of these haemoglobins born 'independently' actually derive from a single ancestral gene.

Researchers from the Institut Jacques Monod (CNRS/Université de Paris), the Laboratoire Matière et Systèmes Complexes (CNRS/Université de Paris), the Station Biologique de Roscoff (CNRS/Sorbonne Université), the Universities of Saint Petersburg (Russia) and Rio de Janeiro (Brazil), conducted this research on Platynereis dumerilii, a small marine worm with red blood.

It is considered to be an animal that evolved slowly, because its genetic characteristics are close to those of the marine ancestor of most animals, Urbilateria(1). Studying these worms by comparing them with other species with red blood has helped in tracing back to the origins of haemoglobins.

The research focused on the broad family to which haemoglobins belong: globins, proteins present in almost all living beings that 'store' gases like oxygen and nitric oxide. But globins usually act inside the cells because they do not circulate in the blood like haemoglobin.

This work shows that in all species with red blood, it is the same gene that makes a globin called 'cytoglobin' that independently evolved to become a haemoglobin-encoding gene. This new circulating molecule made oxygen transport more efficient in their ancestors, who became larger and more active.

Scientists now want to change scale and continue this work by studying when and how the different specialized cells of bilaterian vascular systems emerged.

(1)Urbilateria is the last common ancestor of bilaterians, i.e. animals with bilateral (left-right) symmetry and complex organs, apart from species with simpler organization such as sponges and jellyfish.

Credit: 
CNRS

Significant disparities in telemedicine use, especially among older and POC patients

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends, it has impacted the way many receive medical care. Historically, the United States has been relatively slow to broadly adopt telemedicine, largely emphasizing in-person visits.

However, the COVID-19 pandemic, especially in the spring of 2020, necessitated increased use of virtual or phone call visits, even prompting the Center for Medicare and Medicaid Services (CMS) to relax some of its regulations, primarily for video-based telemedicine. These large scale changes made telemedicine exponentially more popular than it had been even at the start of the calendar year.

But while this was a positive for those who otherwise would have delayed or foregone care due to the pandemic, a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania, published in JAMA Network Open, uncovered significant inequities, particularly by race/ethnicity, socioeconomic status, age, and when someone needed to use a language other than English.

"As we begin to establish novel ways of caring for our patients via telemedicine, it is critical that we make the foundation of this new way forward equitable," said the study's senior author, Srinath Adusumalli, MD, an assistant professor of Cardiovascular Medicine and the University of Pennsylvania Health System assistant chief medical information officer for connected health. "We hope that regulatory and payer organizations recognize potential inequities that could be introduced by policies they create -- which might include not reimbursing for telephone visits, and potentially leading to lack of access to care for particular patient populations, specifically those disproportionately affected by events like the COVID-19 crisis."

The researchers, who included the study's lead author, Lauren Eberly, MD, a clinical fellow in Cardiovascular Medicine, examined data for nearly 150,000 patients of a large, academic medical system. All of these patients had been previously scheduled to have a primary care or ambulatory specialty visit between March 16 and May 11, 2020. This time period coincided with the first surge of coronavirus in the health system's region, and was also amid stay-at-home orders in the area.

Of the patients who had visits previously scheduled, a little more than half, roughly 81,000 (54 percent), conducted their visits via telemedicine, the data showed. And within that segment, less than half, nearly 36,000, (46 percent) had visits conducted via video.

When these visits were broken down by the patients' characteristics, some clear inequities were found. Overall, patients who were older than 55 were 25 percent less likely than the average patient to successfully participate in a telemedicine visit, with people older than 75 being 33 percent less likely. People who identified as Asian were 31 percent less likely to conduct a telemedicine visit, and those who did not speak English were 16 percent less likely. Using Medicaid for insurance also made patients less likely to successfully conduct a telemedicine visit by 7 percent.

Because of the relaxation of CMS rules surrounding video-based telemedicine early in the pandemic, it's important to consider that mode of telemedicine in a class by itself. So when those numbers were examined, some of the same groups showed even less favorable numbers than they had for overall telemedicine use. For instance, people over 55 were at least 32 percent less likely to conduct a video visit, with those over 75 being 51 percent less likely.

Meanwhile, some groups of people were shown to have significant disparities in video-based telemedicine even if they hadn't displayed them for overall telemedicine use. This likely means that they didn't have problems accessing telemedicine if it was phone or audio-based, but video was not as accessible to them. More, women were 8 percent less likely to participate in a video visit than men, Latinx patients were 10 percent less likely than White patients, and Black people 35 percent less likely than White people. Patients with lower household incomes were also less likely to conduct a video visit, with those making less than $50,000 being 43 percent less likely.

While the CMS has recently attempted to make phone call-based telemedicine easier to access from a reimbursement perspective, the researchers believe their findings show that there needs to be equal consideration for all forms of telemedicine moving forward.

"It is critical that complete payment parity for all types of telemedicine visits, by all insurance payers, is guaranteed permanently," Eberly said. "Less reimbursement for telephone visits may disproportionately and unjustly hurt clinics and providers that care for minority and poorer patients."

Penn Medicine has long implemented a practical approach to root out technical issues that may play a role in access issues. Specifically, professionals within the health system work with patients to assess whether they have the technical ability to successfully have a visit. That includes checking Wi-Fi speed and whether the patient has devices physically capable of conducting the visit.

Something since the start of the COVID-19 outbreak that Adusumalli said Penn Medicine addressed was the inequity found for non-English speakers.

"One concrete thing that has already been addressed, based on the results of this study, was adding one-click interpreter integration for more than 40 video-based languages and greater than 100 audio-based languages for both inpatient and outpatient telemedical care throughout our enterprise," he explained.

Moving forward, the researchers hope they can uncover more ways to make telemedicine work for everyone, including facilitating broadband and digital device access.

"We currently have broader research underway to better characterize what patient-specific and provide-specific barriers exist," Eberly said. "If we can understand these barriers, it could help guide telemedicine implementation strategies that will benefit everyone."

Credit: 
University of Pennsylvania School of Medicine

Scientists turned toxic pesticide into treatment against antibiotic-resistant bacteria

N-Aryl-C-nitroazoles are an important class of heterocyclic compounds. They are used as pesticides and fungicides. However, these substances could be toxic to humans and cause mutations. As they are not frequently used, there is little data about them in the medicinal chemistry literature. However, it has been suggested recently that the groups of compounds that are traditionally avoided can help to fight pathogenic bacteria. Yet, to reduce toxic effects, a great amount of work must be carried out at the molecular level, accurate optimization of the molecular environment of the nitro-heteroaromatic "warhead". The validity of this approach was demonstrated in the early 2000s through the development of anti-tuberculosis drugs delamanid and pretomanid, currently approved for medical use. They act like prodrugs, that is, the substance itself is inactive, but acquires new properties when it enters the human body.

In terms of this work, scientists from the Baltic Federal University together with colleagues from St. Petersburg State University, the L. Pasteur Research Institute of Epidemiology and Microbiology, and the Research Institute of Phthisiopulmonology in St. Petersburg, are looking for new effective antibacterial drugs, studying various nitrogen heteroaromatic compounds with a nitro group which might be used in medicine further. The compound OTB-021 was found to work well against drug-sensitive strains of tuberculosis pathogens, but was powerless against strains of pathogens that belong to the so-called ESKAPE panel. ESKAPE is an abbreviation for the names of bacterial species most often developing resistance to antibiotics: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter aerogenes. It is a kind of a pun: "eskape" sounds like "escape", and the bacteria of this panel are known to be resistant to most of the known antibiotics, that is, they seem to "escape" from drugs.

To understand how to modify the compound so that it could act on these pathogenic bacteria the scientists constructed two isomeric (identical in the atomic arrangement) series based on OTB-021. Side amino groups changed their position to make the aromatic nitrogen-rich core of the substance more compact, this should reduce the toxicity of the substance. The sensitivity of microorganisms to a new compound was tested via disk diffusion method. Zones of the inhibition of bacterial growth by antibiotic disks and dried solution of the compound in Petri dishes were measured.

It turned out that the ESKAPE bacteria were easily suppressed by the new substances. The minimal concentration of the chemical that prevents the growth of bacteria (μg / ml) for the tested substance shows a result comparable to the use of a ml of the antibiotic ciprofloxacin: for example, 0.3 μg / ml of an antibiotic for Enterococcus acts the same as 2 μg / ml of one of the new substances.

"Starting from the structure of the antimycobacterial OTB-021 which has no activity against ESKAPE pathogens, we developed, synthesized, and tested two isomeric series of novel analogs with an amino group that changes its position in the structure." These compounds can inhibit the growth of all ESKAPE pathogens. Probably, they will help to develop new effective drugs against bacterial diseases which are sometimes very difficult to treat," says Mikhail Krasavin, Doctor of Chemical Science, Professor of the Russian Academy of Sciences, professor and researcher at the Immanuel Kant Baltic Federal University.

Credit: 
Immanuel Kant Baltic Federal University

Flag leaves could help top off photosynthetic performance in rice

video: A team from the University of Illinois and the International Rice Research Institute (IRRI) found that some flag leaves of different varieties of rice transform light and carbon dioxide into carbohydrates better than others, potentially opening new opportunities for breeding higher yielding rice varieties.

Learn more in the press release: https://bit.ly/2KLxQtH. Check out the original paper: https://doi.org/10.1093/jxb/eraa520

Image: 
Amanda Nguyen/RIPE project

The flag leaf is the last to emerge, indicating the transition from crop growth to grain production. Photosynthesis in this leaf provides the majority of the carbohydrates needed for grain filling--so it is the most important leaf for yield potential. A team from the University of Illinois and the International Rice Research Institute (IRRI) found that some flag leaves of different varieties of rice transform light and carbon dioxide into carbohydrates better than others. This finding could potentially open new opportunities for breeding higher yielding rice varieties. 

Published in the Journal of Experimental Botany, this study explores flag leaf induction--which is the process that the leaf goes through to "start up" photosynthesis again after a transition from low to high light. This is important because the wind, clouds, and movement of the sun across the sky cause frequent fluctuations in light levels. How quickly photosynthesis adjusts to these changes has a major influence on productivity. 

For the first time, these researchers revealed considerable differences between rice varieties in the ability of flag leaves to adjust to fluctuating light. They also showed that the ability to adjust differs between the flag leaf and leaves formed before flowering. Six rice varieties chosen to represent the breadth of genetic variation across a diverse collection of more than 3000 were analyzed as a first step in establishing if there was variation in ability to cope with fluctuations in light. 

In this study, they discovered the flag leaf of one rice variety that began photosynthesizing nearly twice (185%) as fast as the slowest. Another top-performing flag leaf fixed 152% more sugar. They also found large differences (77%) in how much water the plant's flag leaves exchanged for the carbon dioxide that fuels photosynthesis. Additionally, they found that water-use efficiency in flag leaves correlated with water-use efficiency earlier in development of these rice varieties, suggesting that water-use efficiency in dynamic conditions could be screened for at younger stages of rice development. 

"What's more, we found no correlation between the flag leaf and other leaves on the plant, aside from water-use efficiency, which indicates that both kinds of leaves may need to be optimized for induction," said Stephen Long, Illinois' Ikenberry Endowed University Chair of Crop Sciences and Plant Biology. "While this means more work for plant scientists and breeders, it also means more opportunities to improve the plant's photosynthetic efficiency and water use. Improving water use is of increasing importance, as agriculture already accounts for over 70% of human water use, and rice is perhaps the largest single part of this."

Confirming their previous study in New Phytologist, they found no correlation between data collected in fluctuating and steady-state conditions, where the rice plants were exposed to constant high light levels. This finding adds to a growing consensus that researchers should move away from research dependent on steady-state measurements. 

"We're realizing the need for our experiments to more accurately reflect the reality that these plants experience out the field," said first-author Liana Acevedo-Siaca, a postdoctoral researcher at Illinois. "We need to focus our efforts on capturing the dynamic conditions so we can improve crops to be productive in the real world, not laboratories." 

Credit: 
Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign

UCLA scientists develop high-throughput mitochondria transfer device

LOS ANGELES -- Scientists from the UCLA Jonsson Comprehensive Cancer Center have developed a simple, high-throughput method for transferring isolated mitochondria and their associated mitochondrial DNA into mammalian cells. This approach enables researchers to tailor a key genetic component of cells, to study and potentially treat debilitating diseases such as cancer, diabetes and metabolic disorders.

A study, published today in the journal Cell Reports, describes how the new UCLA-developed device, called MitoPunch, transfers mitochondria into 100,000 or more recipient cells simultaneously, which is a significant improvement from existing mitochondrial transfer technologies. The device is part of the continued effort by UCLA scientists to understand mutations in mitochondrial DNA by developing controlled, manipulative approaches that improve the function of human cells or model human mitochondrial diseases better.

"The ability to generate cells with desired mitochondrial DNA sequences is powerful for studying how genomes in the mitochondria and nucleus interact to regulate cell functions, which can be critical for understanding and potentially treating diseases in patients," said Alexander Sercel, a doctoral candidate at the David Geffen School of Medicine at UCLA and co-first author of the study.

Mitochondria, often known as the 'powerplant' of a cell, are inherited from a person's mother. They rely on the integrity of the mitochondrial DNA to perform their essential functions. Inherited or acquired mutations of the mitochondrial DNA can significantly impair energy production and may result in debilitating diseases.

Technologies for manipulating mitochondrial DNA lag behind advances for manipulating DNA in the nucleus of a cell and could potentially help scientists develop disease models and regenerative therapies for disorders caused by these mutations. Current approaches, however, are limited and complex, and for the most part can only deliver mitochondria with desired mitochondrial DNA sequences into a limited number and variety of cells.

The MitoPunch device is simple to operate and allows for consistent mitochondrial transfers from a wide range of mitochondria isolated from different donor cell types into a multitude of recipient cell types, even for non-human species, including for cells isolated from mice.

"What sets MitoPunch apart from other technologies is an ability to engineer non-immortal, non-malignant cells, such as human skin cells, to generate unique mitochondrial DNA-nuclear genome combinations," said co-first author Alexander Patananan, a UCLA postdoctoral scholar, who now works at Amgen. "This advance allowed us to study the impact of specific mitochondrial DNA sequences on cell functions by also enabling the reprogramming of these cells into induced pluripotent stem cells that were then differentiated into functioning fat, cartilage, and bone cells."

MitoPunch was created in the labs of Dr. Michael Teitell, director of the Jonsson Cancer Center and professor of pathology and laboratory medicine, Pei-Yu (Eric) Chiou, professor of mechanical and aerospace engineering at the UCLA Henry Samueli School of Engineering and Applied Science, and Ting-Hsiang Wu, from ImmunityBio, Inc., Culver City, CA.

MitoPunch builds upon prior technology and a device called a photothermal nanoblade, which the team developed in 2016. But unlike the photothermal nanoblade, which requires sophisticated lasers and optical systems to operate, MitoPunch works by using pressure to propel an isolated mitochondrial suspension through a porous membrane coated with cells. The researchers propose that this applied pressure gradient creates the ability to puncture cell membranes at discrete locations, allowing the mitochondria direct entry into recipient cells, followed by cell membrane repair.

"We knew when we first created the photothermal nanoblade that we would need a higher-throughput, simpler to use system that is more accessible for other laboratories to assemble and operate," said Teitell, who is also the chief of the division of pediatric and developmental pathology and a member of the UCLA Broad Stem Cell Research Center. "This new device is very efficient and allows researchers to study the mitochondrial genome in a simple way -- swapping it from one cell into another -- which can be used to uncover the basic biology that governs a broad range of cell functions and could, one day, offer hope for treating mitochondrial DNA diseases."

Credit: 
University of California - Los Angeles Health Sciences

College football players underestimate risk of injury and concussion

AURORA, Colo. (Dec. 29, 2020) - College football players may underestimate their risk of injury and concussion, according to a new study published today in JAMA Network Open.

Christine Baugh, PhD, MPH, assistant professor of medicine at the University of Colorado School of Medicine and member of the CU Center for Bioethics and Humanities, is the corresponding author of the article, "Accuracy of US College Football Players' Estimates of Their Risk of Concussion or Injury."

Baugh and co-authors report on survey results of 296 college football players from four teams in the Power 5 Conferences of the National Collegiate Athletic Association. Athletes were surveyed in 2017. The researchers found that between 43 percent and 91 percent of respondents underestimated their risk of injury and between 42 percent and 63 percent underestimated their risk of concussion.

To measure the accuracy of football players' risk estimations, the researchers modeled individual athletes' probabilities of sustaining a concussion or injury and compared model estimates to athlete perceptions. While recognizing that many people underestimate health risks, the authors point out that the risks college football athletes face may be more severe or debilitating than those faced by many in the general population. Given this elevated risk profile, they say it is concerning that athletes tend to underestimate the likelihood of these risks. These results raise questions about informed consent and how much risk should be acceptable in the context of a game, Baugh and her co-authors write.

"That athletes underestimated their risk of concussion and injury in this study raises important ethical considerations," Baugh and her colleagues write. "What is the threshold for college athletes to be sufficiently informed of the risks and benefits of football to make decisions that align with their values and preferences?"

Credit: 
University of Colorado Anschutz Medical Campus

The puzzle of nonhost resistance: why do pathogens harm some plants but not others?

image: Ralph Panstruga & Matthew Moscou

Image: 
Ralph Panstruga & Matthew Moscou

People have puzzled for years why pathogen Phytophthora infestens causes the devastating late blight disease, source of the Irish Potato famine, on potatoes, but has no effect at all on plants like apple or cucumber. How are apple trees and cucumber plants able to completely shake off this devastating pathogen? Agricultural scientists have wondered for years: if this resistance is so complete and persists over so many generations, is there some way we could transfer it to susceptible plants like wheat and thereby stop disease?

Why is it so important to determine the molecular basis of nonhost resistance?

There are many examples of plants that are susceptible to one pathogen but able to resist another closely related pathogen. By uncovering the mechanism behind resistance, we can obtain a deeper understanding of the plant immune system and can also uncover previously unknown aspects of immune signaling and regulation, which can help scientists improve resistance against a broader spectrum of pathogens.

This question has always been important as pathogens are a consistent threat to agriculture, limiting how much food is produced and where crops can be grown. Scientists continue to learn ways to reduce the impact of disease, through the development of pesticides, implementing new practices in the field, and breeding crops with enhanced resistance.

However, the modern world inadvertently undermines these efforts in a number of ways. Globalization and increased movement have contributed to the spread of pathogens into new environments. A prominent example is the recent emergence of wheat blast disease caused by the fungus Magnaporthe oryzae, which for a long time was unable to colonize wheat.

"The field of nonhost resistance sets out to identify novel ways to engineer resistance to these plant pathogens, guided by approaches that already exist in nature," explained Matthew Moscou, a scientist at The Sainsbury Laboratory in Norwich, United Kingdom. "This question is fundamental to understanding why some plants get infected by a particular pathogen and others don´t, and, vice versa, why a given pathogen can only successfully colonize a limited number of plant species, which collectively form its host range."

What do we know about nonhost resistance?

Scientists have learned that nonhost resistance is a feature controlled by many genes and largely governed by the characteristic attributes of a given plant-pathogen constellation. Pre-existing and induced physical barriers, such as the plant cuticle, and the secretion of antimicrobial molecules are often key factors in nonhost resistance. More recently scientists have recognized the interplay of host NLR-type immune sensors and secreted pathogen effector proteins as another important determinant of nonhost resistance.

What don't we know about nonhost resistance?

"While the contribution of microbial commensals (microbes that naturally inhabit plant organs without causing any harm) to plant immunity has emerged during the past few years, their explicit role in nonhost resistance has not been demonstrated yet", said Ralph Panstruga, a scientist at RWTH Aachen University in Germany. "Our knowledge on nonhost resistance largely relies on findings obtained in a handful of (model) angiosperm plant species that are genetically very tractable. We do not know yet to what extent these insights can be generalized, especially with respect to non-angiosperms."

While there is a lot we don't know about nonhost resistance, recent advances in technology, such as DNA sequencing methods, will make it easier for scientists to learn more. As for understanding the contribution of microbial commensals, scientists have recently been able to explore this aspect through reconstitution experiments with synthetic microbial communities in combination with germ-free plant systems. These tools were only recently established for some model plant species and are not yet available for many agriculturally important crops.

What can come from answering this question?

Learning more about nonhost resistance will help scientists better appreciate that susceptibility and resistance are the extreme outcomes of interactions between plants and pathogens, with all kinds of intermediate forms possible. Scientists may also discover undiscovered of plant pathogens on some species, which will enhance disease control strategies. Answering this question will also help scientists further comprehend whether microbial commensals contribute to resistance, which could form the basis for future plant protection measures. Finally, these insights will complete our picture of the plant immune system.

For the full review, read "What is the Molecular Basis of Nonhost Resistance?" published in the November issue of the MPMI journal. This article is the first in a series of ten reviews exploring the top 10 unanswered questions in molecular plant-microbe interactions, which came out of a crowdsourcing initiative spearheaded by the MPMI journal's editorial board at the 2019 International Congress on Molecular Plant-Microbe Interactions in Glasgow, Scotland.

When meeting attendees Panstruga and Moscou heard about the quest to identify the top 10 unanswered questions in MPMI, they were immediately fascinated. When they saw the final list, they were drawn to the question about nonhost resistance, a plant defense that provides immunity to all members of a plant species against a microorganism that is harmful to other plant species.

"Since we both have published expertise in the area of nonhost resistance, it was somewhat self-evident that we could contribute with a review article to this relevant question," said Panstruga. "We felt for quite some time that some concepts and terms in the field are ambiguous and possibly misleading, and that it would be just the right time to sum up the present knowledge, but also to clarify a few aspects and to raise a few fresh ideas."

Credit: 
American Phytopathological Society

Army research leads to more effective training model for robots

image: New Army research reduces the unpredictability of current training reinforcement learning policies so that they are more practically applicable to physical systems, especially ground robots. These learning components will permit autonomous agents to reason and adapt to changing battlefield conditions.

Image: 
(Photo illustration / U.S. Army)

ADELPHI, Md. -- Multi-domain operations, the Army's future operating concept, requires autonomous agents with learning components to operate alongside the warfighter. New Army research reduces the unpredictability of current training reinforcement learning policies so that they are more practically applicable to physical systems, especially ground robots.

These learning components will permit autonomous agents to reason and adapt to changing battlefield conditions, said Army researcher Dr. Alec Koppel from the U.S. Army Combat Capabilities Development Command, now known as DEVCOM, Army Research Laboratory.

The underlying adaptation and re-planning mechanism consists of reinforcement learning-based policies. Making these policies efficiently obtainable is critical to making the MDO operating concept a reality, he said.

According to Koppel, policy gradient methods in reinforcement learning are the foundation for scalable algorithms for continuous spaces, but existing techniques cannot incorporate broader decision-making goals such as risk sensitivity, safety constraints, exploration and divergence to a prior.

Designing autonomous behaviors when the relationship between dynamics and goals are complex may be addressed with reinforcement learning, which has gained attention recently for solving previously intractable tasks such as strategy games like go, chess and videogames such as Atari and Starcraft II, Koppel said.

Prevailing practice, unfortunately, demands astronomical sample complexity, such as thousands of years of simulated gameplay, he said. This sample complexity renders many common training mechanisms inapplicable to data-starved settings required by MDO context for the Next-Generation Combat Vehicle, or NGCV.

"To facilitate reinforcement learning for MDO and NGCV, training mechanisms must improve sample efficiency and reliability in continuous spaces," Koppel said. "Through the generalization of existing policy search schemes to general utilities, we take a step towards breaking existing sample efficiency barriers of prevailing practice in reinforcement learning."

Koppel and his research team developed new policy search schemes for general utilities, whose sample complexity is also established. They observed that the resulting policy search schemes reduce the volatility of reward accumulation, yield efficient exploration of an unknown domains and a mechanism for incorporating prior experience.

"This research contributes an augmentation of the classical Policy Gradient Theorem in reinforcement learning," Koppel said. "It presents new policy search schemes for general utilities, whose sample complexity is also established. These innovations are impactful to the U.S. Army through their enabling of reinforcement learning objectives beyond the standard cumulative return, such as risk sensitivity, safety constraints, exploration and divergence to a prior."

Notably, in the context of ground robots, he said, data is costly to acquire.

"Reducing the volatility of reward accumulation, ensuring one explores an unknown domain in an efficient manner, or incorporating prior experience, all contribute towards breaking existing sample efficiency barriers of prevailing practice in reinforcement learning by alleviating the amount of random sampling one requires in order to complete policy optimization," Koppel said.

The future of this research is very bright, and Koppel has dedicated his efforts towards making his findings applicable for innovative technology for Soldiers on the battlefield.

"I am optimistic that reinforcement-learning equipped autonomous robots will be able to assist the warfighter in exploration, reconnaissance and risk assessment on the future battlefield," Koppel said. "That this vision is made a reality is essential to what motivates which research problems I dedicate my efforts."

The next step for this research is to incorporate the broader decision-making goals enabled by general utilities in reinforcement learning into multi-agent settings and investigate how interactive settings between reinforcement learning agents give rise to synergistic and antagonistic reasoning among teams.

According to Koppel, the technology that results from this research will be capable of reasoning under uncertainty in team scenarios.

Credit: 
U.S. Army Research Laboratory

Protein twist and squeeze confers cancer drug resistance

video: The ABCB1 protein squeezes fat-soluble compounds out of the cell through a major twist in the protein structure.

Image: 
Kyoto University iCeMS

In 1986, cellular biochemist Kazumitsu Ueda, currently at Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS), discovered that a protein called ABCB1 could transport multiple chemotherapeutics out of some cancer cells, making them resistant to treatment. How it did this has remained a mystery for the past 35 years. Now, his team has published a review in the journal FEBS Letters, summarizing what they have learned following years of research on this and other ATP-binding cassette (ABC) transporter proteins.

ABC transporter proteins are very similar across species and have various transportation roles: importing nutrients into cells, exporting toxic compounds outside them, and regulating lipid concentrations within cell membranes.

ABCB1 is one of these proteins, and is responsible for exporting toxic compounds out of the cell in vital organs such as the brain, testes, and placenta. Sometimes, though, it can also export chemotherapeutic drugs from cancer cells, making them resistant to treatment. The protein lies across the cell membrane, with one end reaching into the cell and the other poking out into the surrounding space. Even though scientists have known its roles and structure for years, exactly how it functions has been unclear.

Ueda and his team crystalized the ABCB1 protein before and after it exported a compound. They then conducted X-ray tests to determine the differences between the two structures. They also conducted analyses using ABCB1 fused with fluorescent proteins to monitor the conformational changes during transport.

They found that compounds destined for export access ABCB1's cavity through a gate in the part of the protein lying inside of the cell membrane. The compound rests at the top of the cavity, where it attaches to molecules, triggering a structural change in the protein. This change requires energy, which is derived from the energy-carrying molecule adenosine triphosphate (ATP). When magnesium ions bind to ATP, the part of ABCB1 inside the cell packs tightly in on itself and tilts, causing its cavity to shrink and then close. This opens the protein's exit gate. ATP is also involved in making ABCB1 progressively rigid from its bottom to its top, leading to a twist and squeeze motion that expels the compound into the extracellular space.

"This mechanism is distinct from those of other transporter proteins," says Ueda. "We expect our work will facilitate the study of other ABC proteins, such as those involved in cholesterol homeostasis."

Credit: 
Kyoto University

Large transporter protein linked to schizophrenia

image: Abnormalities in the cholesterol transport protein ABCA13 have been shown to lead to schizophrenia in a mouse model.

Image: 
Mindy Takamiya/Kyoto University iCeMS

Scientists have suspected mutations in a cellular cholesterol transport protein are associated with psychiatric disorders, but have found it difficult to prove this and to pinpoint how it happens. Now, Kazumitsu Ueda of Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS) and colleagues in Japan have provided evidence that mice with disrupted ABCA13 protein demonstrate a hallmark behaviour of schizophrenia. The team investigated ABCA13's functions and published their findings in the Journal of Biological Chemistry.

ABCA13 belongs to a family of cellular transporter proteins called ATP-binding cassette (ABC) proteins, which are involved in moving cholesterol and other molecules into and out of cells. Ueda and his team have been studying ABC proteins for 35 years, giving them extra leverage for uncovering the elusive roles of what is suspected to be the largest of these proteins, ABCA13.

The scientists studied ABCA13 in different types of human cells. They also turned off the gene that codes for the protein in mice. Finally, they investigated the effects of mutated ABCA13 proteins in human cells. The team found that ABCA13 was a large protein localized in cellular vesicles, and helps transport cholesterol from the cell's membrane into the vesicles.

"We found that ABCA13 accelerates the internalization of cholesterol in cells and that its loss of function is associated with the pathophysiology of some psychiatric disorders," says Ueda.

Mice lacking ABCA13 looked normal and had a normal lifespan. But a series of behavioural investigations showed abnormal results for the 'startle response and prepulse inhibition test'. Normally, a weak 'prepulse' stimulus, like a sound, can reduce the feeling of being startled by a subsequent stronger stimulus. However, people with some psychiatric disorders, still feel startled by a main stimulus despite being preceded by a prepulse. The scientists found that both normal mice and the mice lacking ABCA13 had a normal startle response. But only the engineered mice were startled when the startling stimulus was preceded by a prepulse.

The scientists further wanted to know how ABCA1 deletion affected nerve cells in the brain. They found that vesicles in brain nerve endings in the mice that lacked ABCA1 did not accumulate cholesterol. Synaptic nerve vesicles are vital for the transmission of information from one nerve to another, so this malfunction could contribute to the pathophysiology of psychiatric disorders, the researchers say.

Finally, the scientists studied human cells containing mutated versions of ABCA13 thought to be associated with some psychiatric disorders. They found the mutations impaired ABCA13's functions and ability to locate within cellular vesicles.

The team suggests further studies on ABCA13 functions could lead to the development of novel therapeutic strategies for psychiatric disorders like schizophrenia, bipolar disorder and major depression.

Credit: 
Kyoto University

Brain imaging predicts PTSD after brain injury

Philadelphia, December 29, 2020 - Posttraumatic stress disorder (PTSD) is a complex psychiatric disorder brought on by physical and/or psychological trauma. How its symptoms, including anxiety, depression and cognitive disturbances arise remains incompletely understood and unpredictable. Treatments and outcomes could potentially be improved if doctors could better predict who would develop PTSD. Now, researchers using magnetic resonance imaging (MRI) have found potential brain biomarkers of PTSD in people with traumatic brain injury (TBI).

The study appears in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, published by Elsevier.

"The relationship between TBI and PTSD has garnered increased attention in recent years as studies have shown considerable overlap in risk factors and symptoms," said lead author Murray Stein, MD, MPH, FRCPC, a Distinguished Professor of Psychiatry and Family Medicine & Public Health at the University of California San Diego, San Diego, La Jolla, CA, USA. "In this study, we were able to use data from TRACK-TBI, a large longitudinal study of patients who present in the Emergency Department with TBIs serious enough to warrant CT (computed tomography) scans."

The researchers followed over 400 such TBI patients, assessing them for PTSD at 3 and 6 months after their brain injury. At 3 months, 77 participants, or 18 percent, had likely PTSD; at 6 months, 70 participants or 16 percent did. All subjects underwent brain imaging after injury.

"MRI studies conducted within two weeks of injury were used to measure volumes of key structures in the brain thought to be involved in PTSD," said Dr. Stein. "We found that the volume of several of these structures were predictive of PTSD 3-months post-injury."

Specifically, smaller volume in brain regions called the cingulate cortex, the superior frontal cortex, and the insula predicted PTSD at 3 months. The regions are associated with arousal, attention and emotional regulation. The structural imaging did not predict PTSD at 6 months.

The findings are in line with previous studies showing smaller volume in several of these brain regions in people with PTSD and studies suggesting that the reduced cortical volume may be a risk factor for developing PTSD. Together, the findings suggest that a "brain reserve," or higher cortical volumes, may provide some resilience against PTSD.

Although the biomarker of brain volume differences is not yet robust enough to provide clinical guidance, Dr. Stein said, "it does pave the way for future studies to look even more closely at how these brain regions may contribute to (or protect against) mental health problems such as PTSD."

Cameron Carter, MD, Editor of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, said of the work, "This very important study uses magnetic resonance imaging to take the field a step closer to understanding why some people develop PTSD after trauma and others do not. It also lays the groundwork for future research aimed at using brain imaging to help predict that a person is at increased risk and may benefit from targeted interventions to reduce the clinical impact of a traumatic event."

Credit: 
Elsevier

COVID-19 news from <i>Annals of Internal Medicine</i>

Below please find a summary and link(s) of new coronavirus-related content published today in Annals of Internal Medicine. The summary below is not intended to substitute for the full article as a source of information. A collection of coronavirus-related content is free to the public at http://go.annals.org/coronavirus.

1. Review concludes universal mask use by lay persons reduces the spread of viral infections including SARS-CoV-2
Findings affirm policy promised by President-Elect Biden, who will ask Americans on Inauguration Day to wear masks for 100 days

A new narrative review of over 100 research articles concludes that masks and face coverings worn by members of the public reduce the spread of respiratory viral infections including SARS-CoV-2, the virus that causes Covid-19. The virus travels in the air in tiny droplets and particles, which are blocked to some extent even by 'imperfect' cloth face coverings. Wearing a face covering in a crowded indoor space reduces the chance that an infected person will pass the virus on to others. Even small reductions in the transmission rate can lead to large reductions in the number of people becoming infected over time. Read the full text: https://www.acpjournals.org/doi/10.7326/M20-6625.

According to the authors from the University of Oxford, Institute for Advanced Studies, Vienna, Austria, and London School of Economics there is no evidence that masks and face coverings cause serious harm, though they can cause discomfort. There is also no evidence that wearing a mask leads to people stopping other protective behaviors, such as hand-washing. Resistance to mask-wearing is influenced by cultural norms and expectations; in some but not all cultures, the mask symbolizes the loss of autonomy and a threat to individual freedom. In such circumstances, mandated masking should be introduced only if the virus is spreading and cannot be controlled by other means.

The authors say this review is published at a critical time in the pandemic, as over 80 million people are known to have been infected with the virus and at least 1.75 million have so far died. Currently, over half a million people are becoming infected every day. While masks aren't a perfect barrier to the virus, the data strongly support wide-spread mask mandates, as observational studies suggest universal masking reduces transmission.

Media contacts: A PDF for this article is not yet available. Please click the link to read the full text. The lead corresponding author, Thomas Czypionka can be reached at czypionk@ihs.ac.at.

2. Update to 'living review' summarizes latest evidence on mask use among laypersons and health care workers
Researchers from Oregon Health & Sciences University published a fourth update to their living rapid review of evidence evaluating the use of masks among lay persons in the community and health care workers for preventing the spread of respiratory virus infections, including SARS-CoV-2, the virus that causes COVID-19. The update includes 739 citations that were published from early October to early December 2020 using the same search strategies as the original review. One study on the use of masks and the prevention of SARS-CoV-2 infection in a community setting (the DANMASK trial) and two studies in health care settings were added for the update. Read the full text: https://www.acpjournals.org/doi/10.7326/L20-1429.

The DANMASK trial, a good-quality, open-label trial of 6,024 community-dwelling adults in Denmark evaluated the effects of wearing a surgical mask outside of the house, at a time when mask wearing in the community was neither recommended nor common. The trial found that the incidence of SARS-CoV-2 infection among participants was 2.0%. Mask use versus no mask use was associated with a small, non-statistically significant reduction in risk for SARS-CoV-2 infection. The trial was not designed to assess the effects of mask use as source control; in addition, high adherence to other infection control measures (for example, physical distancing and handwashing) could have attenuated potential benefits.

The evidence on mask use in health care settings and risk for SARS-CoV-2 infection was previously assessed as insufficient on the basis of three studies with methodological limitations. Two new cohort studies, both done in the United States, reported on mask use in health care settings. One study of 16,397 health care workers and first responders (86% health care workers) found that use of an N95 or surgical mask all of the time versus not all of the time was associated with a decreased risk for infection. In the second study, done in 20,614 asymptomatic health care workers, risk for infection was reduced with any mask use versus no mask use. An N95 mask was associated with decreased risk versus a surgical mask. However, both studies had methodological limitations, so evidence for various comparisons about mask use in health care settings and risk for SARS-CoV-2 remains insufficient.

Media contacts: A PDF for this article is not yet available. Please click the link to read the full text. The lead corresponding author, Roger Chou, MD, can be reached through the Oregon Health & Sciences newsroom at news@ohsu.edu.

Credit: 
American College of Physicians

The brain network driving changes in consciousness

image: Differences in brain activity between connected and disconnected states of consciousness studied with positron emission tomography (PET) imaging. Activity of the thalamus, anterior (ACC) and posterior cingulate cortices (PCC), and bilateral angular gyri (AG) show the most consistent associations with the state of consciousness (A = general anesthesia, B = sleep). The same brain structures, which are deactivated when the state of consciousness changes to disconnected in general anesthesia or natural sleep (cool colors in the left columns), are reactivated when regaining a connected state upon emergence from anesthesia (warm colors in the right columns).

Image: 
Scheinin et al., <em>JNeurosci</em> 2020

The loss and return of consciousness is linked to the same network of brain regions for both sleep and anesthesia, according to new research published in JNeurosci.

The biological basis of consciousness has confounded scientists for centuries. Our experimental techniques falter, as the effects of sleep and anesthetic drugs alter brain activity beyond changes in consciousness. In addition, behavior does not always reveal someone's state of consciousness. An unresponsive person might still be aware of their surroundings (connected), or unaware but still experiencing their internal world (disconnected).

Scheinin et al. sought networks associated with human consciousness by measuring the brain activity of adult males with PET as they fell asleep and went under anesthesia. The research team woke participants mid-experiment to interview them and confirm their state of connectedness. Changes in connectedness corresponded to the activity of a network comprised of regions deep inside the brain: the thalamus, anterior and posterior cingulate cortex, and angular gyri. These regions exhibited less blood flow when a participant lost connectedness and more blood flow when they regained it. The pattern held true for both sleep and anesthesia, indicating the changes corresponded to connectedness rather than the effects of sleep or drugs, and that the network may be imperative for human consciousness.

Credit: 
Society for Neuroscience

Gut cells sound the alarm when parasites invade

To effectively combat an infection, the body first has to sense it's been invaded, then the affected tissue must send out signals to corral resources to fight the intruder. Knowing more about these early stages of pathogen recognition and response may provide scientists with crucial clues when it comes to preventing infections or treating inflammatory diseases resulting from overactive immunity.

That was the intent behind a new study, led by researchers at the University of Pennsylvania School of Veterinary Medicine, examining infection with the parasite Cryptosporidium. When the team looked for the very first "danger" signals emitted by a host infected with the parasite, they traced them not to an immune cell, as might have been expected, but to epithelial cells lining the intestines, where Cryptosporidium sets up shop during an infection. Known as enterocytes, these cells take up nutrients from the gut, and here they were shown to alert the body to danger via the molecular receptor NLRP6, which is a component of what's known as the inflammasome.

"You can think about the inflammasome as an alarm system in a house," says Boris Striepen, a professor in the Department of Pathobiology at Penn Vet and senior author on the paper, which is publishing in the journal Proceedings of the National Academy of Sciences. "It has various components--like a camera that watches the door, and sensors on the windows--and once triggered it amplifies those first signals to warn of danger and send a call for help. Cells have these different components as well, and now we've provided maybe the clearest example yet of how a particular receptor in the gut is acting as a sensor for an important intestinal infection."

Typically, Striepen says, researchers have focused on immune cells, like macrophages and dendritic cells, as being the first to detect foreign invaders, but this new finding underscores that cells not normally thought of as part of the immune system--in this case intestinal epithelial cells--are playing key roles in how how an immune response gets launched.

"There is a growing body of literature that is really appreciating what epithelial cells are doing to help the immune system sense pathogens," says Adam Sateriale, first author on the paper who was a postdoc in Striepen's lab and now leads his own lab at the Francis Crick Institute in London. "They seem to be a first line of defense against infection."

Striepen's lab has devoted considerable attention to Cryptosporidium, which is a leading cause of diarrheal disease that can be deadly in young children in resource-poor areas around the world. Cryptosporidium is also a threat to people in well-resourced environments, causing half of all water-borne disease outbreaks in the United States. In veterinary medicine, it's known for infecting calves, stunting their growth. These infections have no effective treatment and no vaccine.

In the current work, Striepen, Sateriale and colleagues took advantage of a naturally occurring species of mouse Cryptosporidium that they recently discovered mimics human infection in many respects. While the researchers knew T cells help control the parasite in later stages of infection, they began looking for clues as to what happens first.

One important clue is the unfortunate linkage between malnutrition and Cryptosporidium infection. Early infection with Cryptosporidium and the inflammation of the intestine that goes along with it predisposes children to malnutrition and stunted growth; at the same time, children who are malnourished are more susceptible to infection. This can lead to a downward spiral, putting children at greater risk of deadly infections. The mechanisms behind this phenomenon are not well understood.

"That led us to think that maybe some of the danger-sensing mechanisms that can drive inflammation in the gut also play a role in the larger context of this infection," adds Striepen.

Together these linkages inspired the research team to look more closely at the inflammasome and its impact on the course of infection in their mouse model. They did so by removing a key component of the inflammasome, an enzyme called caspase-1. "It turns out that animals that are missing this had much higher levels of infection," Sateriale says.

Further work demonstrated that mice lacking caspase-1 just in intestinal epithelial cells suffered infections as high as those lacking it completely, demonstrationg the crucial role of the epithelial cell.

Consistent with this idea, the Penn Vet-led team showed that, out of a variety of candidate receptors, only loss of the NLRP6 receptor lead to failure to control the infection. NLRP6 is a receptor restricted to epithelial barriers previously linked to sensing and maintaining the intestinal microbiome, bacteria that naturally colonize the gut. However, experiments revealed that mice never exposed to bacteria, and thus lacked a microbiome, also activated their inflammasome upon infection with Cryptosporidium--a sign that this aspect of danger signalling occurs in direct response to parasite infection and independent of the gut bacterial community.

To trace how triggering the intestinal inflammasome led to an effective response, the researchers looked at some of the signalling molecules, or cytokines, typically associated with inflammasome activation. They found that infection leads to release of IL-18, with those animals that lack this cytokine or the ability to release it showing more severe infection.

"And when you add back IL-18, you can rescue these mice," Sateriale says, nearly reversing the effects of infection.

Striepen, Sateriale, and colleagues believe there's a lot more work to be done to find a vaccine against Cryptosporidium. But they say their findings help illuminate important aspects of the interplay between the parasite, the immune system, and the inflammatory response, relationships that may inform these translational goals.

Moving forward, they are looking to the later stages of Cryptosporidium infection to see how the host successfully tamps it down. "Now that we understand how infection is detected, we'd like to understand the mechanisms by which it is controlled," Sateriale says. "After the system senses a parasite, what is done to restrict their growth and kill them?"

Credit: 
University of Pennsylvania

$3.9M project on self-deleting genes takes aim at mosquito-borne diseases

To control mosquito populations and prevent them from transmitting diseases such as malaria, many researchers are pursuing strategies in mosquito genetic engineering. A new Texas A&M AgriLife Research project aims to enable temporary "test runs" of proposed genetic changes in mosquitoes, after which the changes remove themselves from the mosquitoes' genetic code.

The project's first results were published on Dec. 28 in Philosophical Transactions of the Royal Society B, titled "Making gene drive biodegradable."

Zach Adelman, Ph.D, and Kevin Myles, Ph.D., both professors in the Texas A&M College of Agriculture and Life Sciences Department of Entomology are the principal investigators. Over five years, the team will receive $3.9 million in funding from the National Institute of Allergy and Infectious Diseases to test and fine-tune the self-deleting gene technology.

"People are wary of transgenes spreading in the environment in an uncontrolled manner. We feel that ours is a strategy to potentially prevent that from happening," Adelman said. "The idea is, can we program a transgene to remove itself? Then, the gene won't persist in the environment.

"What it really comes down to is, how do you test a gene drive in a real-world scenario?" he added. "What if a problem emerges? We think ours is one possible way to be able to do risk assessment and field testing."

A crucial target for mosquito control

Many genetic engineering proposals revolve around inserting into mosquitoes a select set of new genes along with a "gene drive." A gene drive is a genetic component that forces the new genes to spread in the population.

"A number of high-profile publications have talked about using a gene drive to control mosquitoes, either to change them so they can't transmit malaria parasites anymore, or to kill off all the females so the population dies out," Adelman said.

An often-voiced worry is that such genetic changes could carry unintended or harmful consequences.

One plan makes the cut

In the project's first publication, the colleagues describe three ways for an introduced genetic change to remove itself after a designated period of time. The time period could, for instance, be 20 generations of mosquitoes, or about a year. The team modeled how the genes would spread among mosquitoes based on generation times and parameters of an average mosquito's life. Of the three methods, the team has chosen one to pursue further.

This method takes advantage of a process all animals use to repair damaged DNA, Adelman said. Inside cell nuclei, repair enzymes search for repeated genetic sequences around broken DNA strands. The repair enzymes then delete what's between the repeats, he said.

So, Adelman and Myles' team plans to test in fruit flies and mosquitoes a gene drive, a DNA-cutting enzyme and a small repeat of the insect's own DNA.

Once the introduced enzyme cuts the DNA, the insect's own repair tools should jump into action. The repair tools will cut out the genes for the gene drive and the other added sequences. At least, that's what should happen in theory.

Failure is not just an option, it's part of the plan

The team has already started lab work to test different gene drives and determine how long they last in flies and mosquitoes. The goal is to see a gene drive spread rapidly through a lab insect population. After a few generations, the added genes should disappear and the population should again consist of wild-type individuals.

"We assigned various rates of failure for how often the mechanism does not work as expected," Adelman said. "The models predict that even with a very high rate of failure, if it succeeds just 5% of the time, that's still enough to get rid of the transgene."

Credit: 
Texas A&M AgriLife Communications